Circulating microRNAs and cardiomyocyte proliferation in heart failure patients related to 10 years survival

被引:4
|
作者
Wagh, Vilas [1 ,2 ]
Nguemo, Filomain [2 ]
Kiseleva, Zlata [3 ]
Mader, Robert M. [4 ]
Hescheler, Juergen [2 ]
Mohl, Werner [3 ,5 ]
机构
[1] Merck Res Labs, Boston, MA USA
[2] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, Cologne, Germany
[3] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria
[4] Med Univ Vienna, Dept Med 1, Vienna, Austria
[5] Med Univ Vienna, Lazarettgasse 12, A-1090 Vienna, Austria
来源
ESC HEART FAILURE | 2023年 / 10卷 / 06期
基金
奥地利科学基金会;
关键词
Cardiac regeneration; Circulating miRNAs; Embryonic recall; Heart failure; PICSO; CORONARY-SINUS INTERVENTIONS; STEM-CELL THERAPY; EMBRYONIC RECALL; BACK; REGENERATION; ACTIVATION; EXPRESSION; APOPTOSIS; KEY;
D O I
10.1002/ehf2.14516
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Mechanochemical signalling drives organogenesis and is highly conserved in mammal evolution. Regaining recovery in myocardial jeopardy by inducing principles linking cardiovascular therapy and clinical outcome has been the dream of scientists for decades. Concepts involving embryonic pathways to regenerate adult failing hearts became popular in the early millennium. Since then, abundant data on stem cell research have been published, never reaching widespread application in heart failure therapy. Another conceptual access, using mechanotransduction in cardiac veins to limit myocardial decay, is pressure-controlled intermittent coronary sinus occlusion (PICSO). Recently, we reported acute molecular signs and signals of PICSO activating regulatory miRNA and inducing cell proliferation mimicking cardiac development in adult failing hearts. According to a previously formulated hypothesis, 'embryonic recall', this study aimed to define molecular signals involved in endogenous heart repair during PICSO and study their relation to patient survival.Methods and results We previously reported a study on the acute molecular effects of PICSO in an observational non-randomized study. Eight out of the thirty-two patients with advanced heart failure undergoing cardiac resynchronization therapy (CRT) were treated with PICSO. Survival was monitored over 10 years, and coronary sinus blood samples were collected during intervention before and after 20 min and tested for miRNA signalling and proliferation when co-cultured with cardiomyocytes. A numerically lower death rate post-CRT and PICSO as compared with control CRT only, and a non-significant reduction in all-cause mortality risk of 42% was observed (37.5% vs. 54.0%, relative risk = 0.58, 95% confidence interval: 0.17-2.05; P = 0.402). Four miRNAs involved in cell cycle, proliferation, morphogenesis, embryonic development, and apoptosis significantly increased concomitantly in survivors and PICSO compared with a decrease in non-survivors (hsa-miR Let7b, P < 0.01; hsa-miR- 421, P < 0.006; hsa-miR 363-3p, P < 0.03 and hsa-miR 19b-3p P < 0.01). In contrast, three miRNAs involved in proliferation and survival, determining cell fate, and recycling endosomes decreased in survivors and PICSO (hsa miR 101-3p, P < 0.03; hsa-miR 25-3p, P < 002; hsa-miR 30d-5p P < 0.04). In vitro cellular proliferation increased in survivors and lowered in non-survivors showing a pattern distinction, discriminating longevity according to up to 10-year survival in heart failure patients.Conclusions This study proposes that generating regenerative signals observed during PICSO intervention relate to patient outcomes. Morphogenetic pathways induced by periods of flow reversal in cardiac veins in a domino-like pattern transform embryonic into regenerative signals. Studies supporting the conversion of mechanochemical signals into regenerative molecules during PICSO are warranted to substantiate predictive power on patient longevity, opening new therapeutic avenues in otherwise untreatable heart failure.
引用
收藏
页码:3559 / 3572
页数:14
相关论文
共 50 条
  • [21] Exercise Training Restores Circulating microRNAs to Nonpathological Levels in Patients With Heart Failure
    Yamada, Ryo
    Okumura, Satoshi
    Miyazaki, Akane
    Niwa, Yudai
    Tagaya, Manaka
    Ueda, Sayano
    Ishiguro, Tomoya
    Yoshinaga, Masataka
    Fujiwara, Wakaya
    Kato, Yasuchika
    Hayashi, Mutsuharu
    Harada, Masahide
    Ishi, Junichi
    Ozaki, Yukio
    Izawa, Hideo
    CIRCULATION, 2018, 138
  • [22] Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure
    Abu-Halima, Masood
    Meese, Eckart
    Keller, Andreas
    Abdul-Khaliq, Hashim
    Raedle-Hurst, Tanja
    JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [23] Circulating Extracellular Vesicles from Heart Failure Patients Inhibit Human Cardiomyocyte Activities
    Zhen, Ke
    Wei, Xiaojuan
    Zhi, Zelun
    Shang, Shiyu
    Zhang, Shuyan
    Xu, Yilu
    Fu, Xiaochuan
    Cheng, Linjia
    Yao, Jing
    Li, Yue
    Chen, Xia
    Liu, Pingsheng
    Zhang, Hongchao
    JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH, 2024,
  • [24] Circulating MicroRNAs New Avenues for Heart Failure Classification?
    Shah, Ravi V.
    Das, Saumya
    Lewis, Gregory D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (11) : 1314 - 1316
  • [25] Circulating microRNAs correlate with heart failure presence and progression
    D'Alessandra, Y.
    Buzzetti, M.
    Ruggeri, C.
    Beltrami, A. P.
    Carena, M. C.
    Fortini, C.
    Cecaro, F.
    Ferrari, R.
    Cesselli, D.
    Aleksova, A.
    Sponga, S.
    Pompilio, G.
    Colombo, G. I.
    EUROPEAN HEART JOURNAL, 2017, 38 : 829 - 830
  • [26] Circulating microRNAs as Diagnostic and Prognostic Markers for Heart Failure
    Wong, Lee Lee
    Lim, Jia Yuen
    Zhou, Lihan
    Zou, Ruiyang
    Chan, Michelle M. Y.
    Lam, Carolyn S. P.
    Too, Heng-Phon
    Richards, Arthur M.
    CIRCULATION, 2014, 130
  • [27] Transcoronary concentration gradients of circulating microRNAs in heart failure
    De Rosa, Salvatore
    Eposito, Francesca
    Carella, Cristina
    Strangio, Antonio
    Ammirati, Giuseppe
    Sabatino, Jolanda
    Abbate, Fabio Giovanni
    Iaconetti, Claudio
    Liguori, Vincenzo
    Pergola, Valerio
    Polimeni, Alberto
    Coletta, Silvio
    Gareri, Clarice
    Trimarco, Bruno
    Stabile, Giuseppe
    Curcio, Antonio
    Indolfi, Ciro
    Rapacciuolo, Antonio
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (06) : 1000 - 1010
  • [28] Serially measured circulating microRNAs and adverse clinical outcomes in patients with acute heart failure
    van Boven, Nick
    Kardys, Isabella
    van Vark, Laura C.
    Akkerhuis, K. Martijn
    de Ronde, Maurice W. J.
    Khan, Mohsin A. F.
    Merkus, Daphne
    Liu, Zhen
    Voors, Adriaan A.
    Asselbergs, Folkert W.
    van den Bos, Ewout-Jan
    Boersma, Eric
    Hillege, Hans
    Duncker, Dirk J.
    Pinto, Yigal M.
    Postmus, Douwe
    EUROPEAN JOURNAL OF HEART FAILURE, 2018, 20 (01) : 89 - 96
  • [29] Induced Cardiomyocyte Proliferation: A Promising Approach to Cure Heart Failure
    Salama, Abou Bakr M.
    Gebreil, Ahmad
    Mohamed, Tamer M. A.
    Abouleisa, Riham R. E.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (14)
  • [30] Circulating mitochondrial DNA predicts survival in patients with acute heart failure
    Krychtiuk, K. A.
    Lenz, M.
    Maurer, G.
    Huber, K.
    Wojta, J.
    Heinz, G.
    Speidl, W. S.
    EUROPEAN HEART JOURNAL, 2016, 37 : 983 - 983